Ram. it typically takes 1-5 yrs to get a patent on a drug . You're dealing with prior art and USPTO actions . IIRC in the 2010 / 2011 period the patent office originally rejected the Marine patent . Eventually it was approved because AMRN could prove that Vascepa ( AMR101 at the time ) was DEVOID of DHA . Epadel by contrast has up to 10% DHA . Poster North may have a better memory of this period.
AMRN doesn't have this time if they continue on their current path and especially if they use $50m on a share buyback. The reality is that revenue in the US is crashing and revenue growth in the EU is minuscule . And so far mgt has yet to come up with an effective plan to convince the market , they can change that . Which is why the PPS is under $1.